CDC issues new prescription guidelines for opioids

CDC issues new prescription guidelines for opioids

(HealthDay)—A new advisory, from the U.S. Centers for Disease Control and Prevention, stresses that doctors—especially primary care physicians—should try to avoid prescription of opioids whenever possible. Two research letters published online March 15 in the Journal of the American Medical Association highlight the scope of the opioid issue.

In one study, a team led by Hannah Wunsch, M.D., of the Sunnybrook Health Sciences Center in Toronto, tracked prescriptions given to American after low-risk surgeries. The surgeries included a total of 155,297 procedures conducted in the United States for carpal tunnel, , hernia repair, and knee arthroscopy.

Within a week of discharge from the hospital, four out of five patients had filled a prescription for an opioid, and the vast majority of those prescriptions were for Percocet or Vicodin. What's more, dosages for these drugs tended to rise over time, Wunsch's team reported, indicating "an increasing reliance on opioids for postoperative pain relief versus alternative therapies."

A second study led by Brian Bateman, M.D., of Brigham and Women's Hospital in Boston, tracked 2,757,273 patients who'd had a tooth extracted between 2000 and 2010. According to the researchers, within a week of having a tooth pulled, 42 percent of patients filled a prescription for an opioid. Many of the patients were young: 61 percent of 14- to 17-year-olds filled such .

More information: Full Text - CDC Guidelines
Full Text - Wunsch
Full Text - Bateman
More Information

Copyright © 2016 HealthDay. All rights reserved.

Citation: CDC issues new prescription guidelines for opioids (2016, March 16) retrieved 16 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Limit opioid painkiller prescriptions, US regulators say


Feedback to editors